Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines
<p>Abstract</p> <p>Background</p> <p>Many genetic diseases are due to defects in protein trafficking where the mutant protein is recognized by the quality control systems, retained in the endoplasmic reticulum (ER), and degraded by the proteasome. In many cases, the mut...
Main Authors: | Sampson Heidi M, Lam Hung, Chen Pei-Chun, Zhang Donglei, Mottillo Cristina, Mirza Myriam, Qasim Karim, Shrier Alvin, Shyng Show-Ling, Hanrahan John W, Thomas David Y |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://www.ojrd.com/content/8/1/11 |
Similar Items
-
Molecular pathogenesis of long QT syndrome type 2
by: Jennifer L. Smith, et al.
Published: (2016-10-01) -
Rescue of Rare CFTR Trafficking Mutants Highlights a Structural Location-Dependent Pattern for Correction
by: Sónia Zacarias, et al.
Published: (2023-02-01) -
Long QT Syndrome Type 2: Emerging Strategies for Correcting Class 2 <i>KCNH2</i> (<i>hERG</i>) Mutations and Identifying New Patients
by: Makoto Ono, et al.
Published: (2020-08-01) -
The Impact of Highly Effective CFTR Modulators on Growth and Nutrition Status
by: Rosara Bass, et al.
Published: (2021-08-01) -
Elexacaftor Mediates the Rescue of F508del CFTR Functional Expression Interacting with MSD2
by: Roberta Bongiorno, et al.
Published: (2023-08-01)